Affiliation:
1. Department of Medicine (C.A.P.), Division of Metabolism, Endocrinology and Nutrition, University of Washington School of Medicine, Seattle, Washington 98195-6426
2. Department of Medicine and of Biochemistry, Biophysics and Genetics (N.M., A.G.-H.), Program in Molecular Biology and Colorado Cancer Center, University of Colorado Health Sciences Center, Denver, Colorado 80262
3. Department of Molecular Cell Physiology (Y.A.), Tokyo Metropolitan Institute of Medical Science, Tokyo 113-8613, Japan
Abstract
AbstractEpidermal growth factor (EGF) and TRH both produce enhanced prolactin (PRL) gene transcription and PRL secretion in GH4 rat pituitary tumor cell lines. These agents also activate protein kinase C (PKC) in these cells. Previous studies have implicated the PKCε isozyme in mediating TRH-induced PRL secretion. However, indirect studies using phorbol ester down-regulation to investigate the role of PKC in EGF- and TRH-induced PRL gene transcription have been inconclusive. In the present study, we examined the role of multiple PKC isozymes on EGF- and TRH-induced activation of the PRL promoter by utilizing general and selective PKC inhibitors and by expression of genes for wild-type and kinase-negative forms of the PKC isozymes. Multiple nonselective PKC inhibitors, including staurosporine, bisindolylmaleimide I, and Calphostin C, inhibited both EGF and TRH induced rat PRL promoter activity. TRH effects were more sensitive to Calphostin C, a competitive inhibitor of diacylglycerol, whereas Go 6976, a selective inhibitor of Ca2+-dependent PKCs, produced a modest inhibition of EGF but no inhibition of TRH effects. Rottlerin, a specific inhibitor of the novel nPKCδ isozyme, significantly blocked both EGF and TRH effects. Overexpression of genes encoding PKCs α, βΙ, βΙΙ, δ, γ, and λ failed to enhance either EGF or TRH responses, whereas overexpression of nPKCη enhanced the EGF response. Neither stable nor transient overexpression of nPKCε produced enhancement of EGF- or TRH-induced PRL promoter activity, suggesting that different processes regulate PRL transcription and hormone secretion. Expression of a kinase inactive nPKCδ construct produced modest inhibition of EGF-mediated rPRL promoter activity. Taken together, these data provide evidence for a role of multiple PKC isozymes in mediating both EGF and TRH stimulated PRL gene transcription. Both EGF and TRH responses appear to require the novel isozyme, nPKCδ, whereas nPKCη may also be able to transmit the EGF response. Inhibitor data suggest that the EGF response may also involve Ca2+-dependent isozymes, whereas the TRH response appears to be more dependent on diacylglycerol.
Subject
Endocrinology,Molecular Biology,General Medicine
Cited by
23 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献